India to Iraq: Montelukast Export Trade Route

The India to Iraq Montelukast corridor is one of India's established pharmaceutical export routes, with 125 shipments documented worth a combined $2.3M USD. The route is dominated by AJANTA PHARMA LIMITED, which alone accounts for roughly 70% of all export value, reflecting the consolidated nature of India's montelukast manufacturing sector.

Across 22 active suppliers, the average shipment value stands at $18.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with montelukast's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 12.3%, placing it at rank #18 among India's top montelukast export destinations globally.

On the import side, key buyers of Indian montelukast in Iraq include SHAMS AL-THURAYA CO, SHAMS AL-THURAYA CO FOR GENERAL TRA, KAWKAB SCIENTIFIC BUREAU* and 29 others. SHAMS AL-THURAYA CO is the single largest importer with 4 shipments valued at $523.8K USD.

India's montelukast exports to Iraq are driven primarily by a handful of large-scale manufacturers. AJANTA PHARMA LIMITED with 40 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 22 active exporters signals a competitive but concentrated market — buyers in Iraq benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AJANTA PHARMA LIMITED, AJANTA PHARMA LIMITED , SCOTT EDIL PHARMACIA LIMITED — together account for 88% of total trade value on this route. The average shipment value of $18.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as mubact l 10/5 tablets[63036packx3x10 = 1891080tabs]montelukast 10 mg plus levocetirizine dihydrochloride 5 mg as per inv and mubact l 10/5 tablets[61848 x 3 x 10 = 1855440 tablets][montelukast 10 mg plus levocetirizine dihydrochloride 5mg tablet, suggesting that buyers in Iraq tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SHAMS AL-THURAYA CO is the largest importer with 4 shipments worth $523.8K USD — representing 22% of all montelukast imports from India on this route. A total of 32 buyers are active on this corridor.